Refine
Year of publication
- 2016 (268) (remove)
Document Type
- Article (116)
- Conference Proceeding (80)
- Part of a Book (27)
- Book (23)
- Other (10)
- Report (5)
- Doctoral Thesis (3)
- Part of Periodical (2)
- Patent (1)
- Talk (1)
Keywords
- Technical Operations Research (2)
- Additive Manufacturing (1)
- Annulus Fibrosus (1)
- Assessment (1)
- Asymptotic efficiency (1)
- Bacillus atrophaeus (1)
- Balance (1)
- Balanced hypergraph (1)
- Brandfall (1)
- Building Systems (1)
- Business Simulations (1)
- Cardiac myocytes (1)
- Cardiac tissue (1)
- CellDrum (1)
- Censored data (1)
- Co-managed care (1)
- Collaborative robot (1)
- Computational biomechanics (1)
- Controller Parameter (1)
- DNA biosensor (1)
- Designpraxis (1)
- Disc Degeneration (1)
- Diversity (1)
- Drinking Water Supply (1)
- Drug simulation (1)
- Duality (1)
- EN 1993-1-2 (1)
- Effizienz (1)
- Einbetten in das Internet der Dinge (1)
- Elderly (1)
- Electromechanical modeling (1)
- Engineering Education (1)
- Eutectic Silver Copper alloy (1)
- External knee adduction moments (1)
- Fall prevention (1)
- Field effect (1)
- Forschung, pränormativ (1)
- Frequency adaption (1)
- Gamification (1)
- Gender (1)
- Ground-level falls (1)
- Hall’s Theorem (1)
- Heart tissue culture (1)
- Higher Education (1)
- Hodgkin–Huxley models (1)
- Homogenization (1)
- Human-Robot interaction (1)
- Hypergraph (1)
- Hypothesentests (1)
- Induced pluripotent stem cells (1)
- Inotropic compounds (1)
- Intervertebral Disc (1)
- Intradiscal Pressure (1)
- Inverse dynamic problem (1)
- Inverse kinematic problem (1)
- Ion channels (1)
- Koenig’s Theorem (1)
- LAPS (1)
- Label-free detection (1)
- Layer-by-layer adsorption (1)
- Level Control System (1)
- Manipulated variables (1)
- Matching (1)
- Minimal-Ansatz für Embedded-Systeme (1)
- Mixed Integer Programming (1)
- Mixed-Integer Nonlinear Optimisation (1)
- Mobility (1)
- Mobility tests (1)
- Musculoskeletal model (1)
- Nucleus Pulposus (1)
- Optimal Closed Loop (1)
- Optimal Topology (1)
- Optimization (1)
- Parametric Design (1)
- Parametric Modelling (1)
- Path planning (1)
- Pharmacology (1)
- Poly(allylamine hydrochloride) (1)
- Porositat (1)
- Product-integration (1)
- Reference Process Model (1)
- Referenzmodellierung (1)
- Response Surface Method (1)
- SLM (1)
- Safety concept (1)
- Semi-parametric random censorship model (1)
- Serious Games (1)
- Solver Per- formance (1)
- Structuralist Architecture (1)
- Subject-oriented Business Process Management (1)
- Survival analysis (1)
- System Design (1)
- System Design Problem (1)
- TM Forum (1)
- TTIP (1)
- Technical Operation Research (1)
- Telecommunications Industry. (1)
- Tinetti test (1)
- Tragwerksbemessung (1)
- Unternehmensarchitektur (1)
- Unternehmenstransformation (1)
- Vergleich von Experimenten (1)
- Vertex cover (1)
- Volterra integral equation (1)
- Workspace monitoring (1)
- biosensors (1)
- building industry (1)
- chemical sensor (1)
- diversity (1)
- eTOM (1)
- efficiency (1)
- electronic communications markets (1)
- endospores (1)
- energy disspation (1)
- engineering education (1)
- enhanced Telecom Operations Map (eTOM) (1)
- friction (1)
- hiPS cardiomyocytes (1)
- immobilization (1)
- impulsive effects (1)
- industrial research (1)
- ingot (1)
- innovation (1)
- iron and steel industry (1)
- liberalisation (1)
- light-addressable potentiometric sensor (1)
- liquid-storage tank (1)
- liquid-structure interaction (1)
- materials technology (1)
- metal structure (1)
- organosilanes (1)
- plug-based microfluidic device (1)
- regulation (1)
- research project (1)
- research report (1)
- resistance of materials (1)
- seismic response (1)
- silanization (1)
- social responsible engineering (1)
- steel (1)
- structural design (1)
- structure-soil-structure interaction (1)
- testing hypotheses (1)
- wave run-up (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (54)
- Fachbereich Chemie und Biotechnologie (36)
- Fachbereich Bauingenieurwesen (35)
- Fachbereich Elektrotechnik und Informationstechnik (35)
- IfB - Institut für Bioengineering (35)
- Fachbereich Wirtschaftswissenschaften (31)
- Fachbereich Luft- und Raumfahrttechnik (27)
- Fachbereich Maschinenbau und Mechatronik (25)
- Fachbereich Energietechnik (17)
- INB - Institut für Nano- und Biotechnologien (15)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (11)
- Institut fuer Angewandte Polymerchemie (5)
- Nowum-Energy (5)
- Solar-Institut Jülich (5)
- ZHQ - Bereich Hochschuldidaktik und Evaluation (5)
- ECSM European Center for Sustainable Mobility (4)
- Fachbereich Architektur (4)
- FH Aachen (2)
- IBB - Institut für Baustoffe und Baukonstruktionen (2)
- Fachbereich Gestaltung (1)
We study the novel possibilities computer aided design and production open up for the design of building systems. Such systems today can, via individualized mass production, consist of a larger number and more complex parts than previously and therefore be assembled into more complex wholes. This opens up the possibility of designing specialized systems specifically for single buildings. The common order of starting with a building system and designing a building using this system can be reversed to designing a building first and then developing a system specifically for that building. We present and discuss research that incorporates students design projects into research work and fosters links between research and teaching.
Mice that have been genetically humanized for proteins involved in drug metabolism and toxicity and mice engrafted with human hepatocytes are emerging and promising in vivo models for an improved prediction of the pharmacokinetic, drug–drug interaction and safety characteristics of compounds in humans. The specific advantages and disadvantages of these models should be carefully considered when using them for studies in drug discovery and development. Here, an overview on the corresponding genetically humanized and chimeric liver humanized mouse models described to date is provided and illustrated with examples of their utility in drug metabolism and toxicity studies. We compare the strength and weaknesses of the two different approaches, give guidance for the selection of the appropriate model for various applications and discuss future trends and perspectives.
Breast cancer resistance protein (BCRP) is expressed in various tissues, such as the gut, liver, kidney and blood brain barrier (BBB), where it mediates the unidirectional transport of substrates to the apical/luminal side of polarized cells. Thereby BCRP acts as an efflux pump, mediating the elimination or restricting the entry of endogenous compounds or xenobiotics into tissues and it plays important roles in drug disposition, efficacy and safety. Bcrp knockout mice (Bcrp−/−) have been used widely to study the role of this transporter in limiting intestinal absorption and brain penetration of substrate compounds. Here we describe the first generation and characterization of a mouse line humanized for BCRP (hBCRP), in which the mouse coding sequence from the start to stop codon was replaced with the corresponding human genomic region, such that the human transporter is expressed under control of the murine Bcrp promoter. We demonstrate robust human and loss of mouse BCRP/Bcrp mRNA and protein expression in the hBCRP mice and the absence of major compensatory changes in the expression of other genes involved in drug metabolism and disposition. Pharmacokinetic and brain distribution studies with several BCRP probe substrates confirmed the functional activity of the human transporter in these mice. Furthermore, we provide practical examples for the use of hBCRP mice to study drug-drug interactions (DDIs). The hBCRP mouse is a promising model to study the in vivo role of human BCRP in limiting absorption and BBB penetration of substrate compounds and to investigate clinically relevant DDIs involving BCRP.
NVS123 is a poorly water-soluble protease 56 inhibitor in clinical development. Data from in vitro hepatocyte studies suggested that NVS123 is mainly metabolized by CYP3A4. As a consequence of limited solubility, NVS123 therapeutic plasma exposures could not be achieved even with high doses and optimized formulations. One approach to overcome NVS123 developability issues was to increase plasma exposure by coadministrating it with an inhibitor of CYP3A4 such as ritonavir. A clinical boost effect was predicted by using physiologically based pharmacokinetic (PBPK) modeling. However, initial boost predictions lacked sufficient confidence because a key parameter, fraction of drug metabolized by CYP3A4 (ƒₘCYP3A4), could not be estimated with accuracy on account of disconnects between in vitro and in vivo preclinical data. To accurately estimate ƒₘCYP3A4 in human, an in vivo boost effect study was conducted using CYP3A4-humanized mouse model which showed a 33- to 56-fold exposure boost effect. Using a top-down approach, human ƒₘCYP3A4 for NVS123 was estimated to be very high and included in the human PBPK modeling to support subsequent clinical study design. The combined use of the in vivo boost study in CYP3A4-humanized mouse model mice along with PBPK modeling accurately predicted the clinical outcome and identified a significant NVS123 exposure boost (∼42-fold increase) with ritonavir.